
Drones Deliver Millions Of Mosquitos to Prevent Bird Extinctions In Hawai‘i
'Ākohekohe (Palmeria dolei), or crested honeycreeper, is endemic to the island of Maui in Hawaiʻi. ... More The ʻākohekohe is susceptible to mosquito‐transmitted avian malaria and only breeds in high‐elevation wet forests. It is critically endangered with fewer than 2,000 individuals alive today. (Via USFWS / public domain.)
In a brilliant demonstration of multidisciplinary collaboration, a conservation program to save Hawai'i's critically endangered native bird species has taken another step forward. After a team of scientists developed sterile male mosquitoes, the next challenge was to safely deliver them to where they would be most effective in Hawai'i.
Sterile male mosquitoes are created by infecting them with the bacteria, Wolbachia. This bacteria, which naturally occurs in many wild insect species, interferes with reproduction in mosquitoes by 'sterilizing' the males when introduced into mosquito populations like Aedes aegypti. When sterile male Wolbachia-infected mosquitoes mate with invasive wild female Aedes aegypti mosquitoes, the resulting eggs cannot be fertilized and thus, cannot hatch, thereby reducing the mosquito population.
Wolbachia is a maternally transmitted bacterium, where female Wolbachia-carrying Aedes aegypti pass ... More the bacterium to their offspring, thus generating a stable line of Wolbachia-Aedes mosquitoes. Rearing this line of mosquitos in captivity allows humans to easily produce large numbers of incompatible male Wolbachia-Aedes mosquitoes for release. (Credit: The National Environment Agency of Singapore / Public Domain)
Male mosquitoes (regardless of whether they carry Wolbachia) do not bite or transmit disease, and feed only on plant juices and nectar for survival and energy. On the other hand, female mosquitoes do bite because they need a fresh blood meal to produce eggs. Additionally, because Wolbachia-Aedes mosquitoes are not genetically modified, and because Wolbachia bacteria naturally occur in 60% or more wild insects, these mosquitoes are safe.
Where did these 'sterile' male mosquitoes originate?
'These males are descendants of mosquitoes originally collected from Hawai'i and it has taken multiple mosquito generations to breed up enough IIT mosquitoes to supply the project's needs,' said scientific outreach specialist Emma Shelly, who works as the Outreach Manager with Birds, Not Mosquitoes. This is a multi-agency partnership, spearheaded by the American Bird Conservancy, that is working to protect native Hawaiian honeycreepers from extinction caused by avian diseases, particularly avian malaria, transmitted by invasive mosquitoes.
The effort uses the Incompatible Insect Technique (IIT) as a biological 'birth control' method to reduce the spread of mosquito-borne diseases by reducing local mosquito populations by more than 80% (ref). It has been used successfully in a wide range of places and situations around the world to control a variety of mosquito-borne diseases, ranging from dengue fever to malaria.
Do free-roaming female mosquitoes prefer to mate with these IIT male mosquitoes?
'So all things being equal, matings would occur at random,' Ms Shelly told me in email. 'But all things aren't equal because the project is heavily skewing the odds in favor of the incompatible males by releasing them in such large numbers that the wild male mosquitoes are overwhelmed. In this scenario, wild females have significantly more opportunities to encounter IIT males and mate with them.'
This technique is known as 'overflooding' and the 'overflooding ratio' (how many IIT males it takes to overwhelm wild males in a given area) is a key component of the project. In Hawai'i, that ratio is 10:1.
Not only can drones deliver missiles to protect beleaguered civilians from Russian terrorists, but drones can also deliver pods full of IIT male mosquitoes to protect critically endangered Hawai'ian honeycreepers from avian malaria. But the drones used in these biological battles are not the same as those used against Russia, as you might have guessed.
'The drones we use are more common for activities requiring a moderate payload for a drone, like LiDAR, magnetometers, or cinema cameras. They are usually somewhat larger and fly much slower,' Adam Knox, drone pilot and Aerial Deployment of Mosquitoes Project Manager for American Bird Conservancy, told me in email. 'One of the drones we use, the Freefly AltaX is used for movies (can carry a RED Epic or similar) as well as aerial ignition deployment for controlled wildfire burns.'
What makes these particular drones particularly well-designed to carry out their mosquito-delivery job?
'The drones needed to have adequate range and endurance to reach the 3000 acre site that extends over mountainous terrain carrying the payload system and then return home, so much of the testing has been focused on demonstrating this,' Mr Knox explained in email.
Are these drones guided by autopilot or by humans?
'Both,' Mr Knox replied in email. 'A human pilot flies the aircraft manually during takeoffs and landings to precisely navigate around hazards in the forest, then once above the tree canopy, the aircraft is switched into an autopilot mode which allows it to carry out the preplanned mission as the pilot monitors the flight.'
The male mosquitoes are delivered in biodegradable pods. Each drone carries up to 23 mosquito pods in one flight, and each pod contains about 1,000 insects.
'The pods are made of a sterilized biodegradable paper pulp and are not reusable,' Mr Knox explained in email. 'Once released from the air, they fall to the forest floor where they provide protection to the mosquitoes until they're ready to fly away. The pods then begin to break down once exposed to the elements.'
A drone carrying a biodegradable mosquito pod, loaded and ready to deliver. (Credit: Adam Knox, ... More image appears here courtesy of the American Bird Conservancy.)
This effort is the first known instance of specially-designed mosquito pods being dropped by drones. One of several pod design challenges that had to be met before the drone delivery service could be launched was the pods needed to maintain a controlled temperature. Unlike other insect species that have been released directly from drones in other parts of the world, these male mosquitoes are fragile and require containment in temperature-controlled pods.
'It's extremely exciting to have reached this project milestone,' Mr Knox remarked in email. 'The first drone deployments took place in April 2025. It took a lot of hard work and reliance on strong partnerships to reach the point where we could successfully demonstrate the utility and potential of drone aircraft as a tool for this important work, especially in one of the more challenging environments in the world.'
The mosquito deliveries occur over thousands of acres of remote, mountainous terrain that have significant elevational changes, strong winds, and frequent rain. The drones and their release systems had to be tested in these demanding conditions to validate their ability to carry out the basic components of the mission.
Can you imagine dropping mosquitoes in this landscape without falling to your death? Aerial view of ... More the rugged terrain, steep walls and waterfalls at Koolau Forest Reserve East Maui, Hawaii. (Credit: Forest and Kim Starr / CC BY 3.0 US)
Originally, mosquito deliveries began in 2023 with twice weekly helicopter deployments into remote forests on Maui and Kaua'i, but drone deployments are so much safer for the humans delivering the mosquitoes.
'This opens up a lot of possibilities now and into the future,' Mr Knox pointed out. 'With a drone, we have more flexibility with deployment timing in areas that generally have very unpredictable weather, and it's safer because no humans need to ride in the aircraft as pilot and crew to deploy the mosquitoes.'
Your job looks like it's fun. Is it?
'My parents got me a Tyco Wild Thing as my first RC car when I was probably 5 or 6 years old and since then I have been into the RC hobby on and off throughout my life, spanning cars, planes, helicopters and drones,' Mr Knox replied in email. 'To be able to have my professional pursuits overlap with a hobby that brings me joy is something many only dream about so I feel incredibly lucky to have the opportunity to apply this skillset and knowledge toward helping some of the most endangered wildlife on the planet.'
"What we're doing is difficult and it has required a lot of long days for dozens of people scattered across the country working together over multiple years now,' Mr Knox replied in email. 'It's been worth every ounce of effort with what we've been able to learn while getting these specialized IIT mosquitoes out into some of the most challenging landscapes imaginable in order to give these birds a fighting chance at recovery.'
Even as these IIT mosquitoes are being delivered to their targets, are there other conservation efforts ongoing?
'Yes, there are,' Mr Knox replied in email. 'The San Diego Zoo Wildlife Alliance has two facilities in Hawai'i where small populations of several endangered bird species are being kept and captively bred. The sooner mosquitoes are suppressed, the sooner these critically endangered birds can be returned to the wild and begin to re-establish themselves.'
Whilst the IIT mosquito effort is currently the best tool we have for controlling invasive disease-carrying mosquitoes, it works hand in hand with other conservation efforts being led on the ground by Birds, Not Mosquitoes partners, including habitat restoration and invasive species and predator control.
A critially endangered Hawai'ian Kiwikiu (Pseudonestor xanthophrys) or hookbilled honeycreeper. ... More There are fewer than 200 of these birds remaining. (Credit: Robby Kohley, image appears here courtesy of the American Bird Conservancy.)
The mosquito, Aedes aegypti, was initially introduced to the Hawaiian Islands sometime after 1882 by whaling ships, so any ecological role these insects may fill either as prey or pollinators is a recent development. Which is another way to say that it is extremely unlikely that any native bird species has become dependent upon them as a critical food resource. But this invasive mosquito species is quite efficient at transmitting a variety of debilitating diseases to humans, such as dengue, chikugunya, Zika virus, and malaria, just to name a few.
Originally, the Aedes aegypti mosquito was restricted to Hawai'i's lower elevations, which allowed some of Hawai'i's honeycreepers to live at higher elevations and thus survive. However, climate change has allowed mosquitoes to expand their range upwards, so now all of Hawai'i's remaining native bird species are in danger of vanishing forever.
'Without significantly reducing invasive mosquito populations, multiple native bird species will disappear forever in the near future,' said Chris Farmer, the American Bird Conservancy's Hawai'i Program Director.
How many native Hawai'ian bird species have been driven extinct by avian malaria so far?
'At least 33 species of honeycreeper are now extinct, and many of the 17 that remain, including the Kiwikiu and ʻĀkohekohe on Maui, and ʻAkekeʻe on Kauaʻi, are highly endangered,' Dr Farmer replied. 'Last year, the ʻAkikiki became functionally extinct in the wild, and mosquitoes could cause other species to quickly decline and vanish if no action is taken.'
The ʻakikiki (Oreomystis bairdi), also called the Kauaʻi creeper, is now functionally extinct, ... More thanks to avian malaria spread by invasive mosquitoes. (Credit: Robby Kohley, image appears here courtesy of American Bird Conservancy.)
'Reducing invasive mosquito populations is absolutely critical in preventing the extinction of Hawai'i's vulnerable honeycreepers,' Dr Farmer continued. 'We have the technology to break the avian disease cycle in Hawai'i, and a fighting chance to restore populations. We are the generation that can save honeycreepers like Maui's Kiwikiu, and with a population of less than 150 individuals, these drone and mosquito suppression advancements have come just in time.'
I highly recommend that you watch this moving video, Vanishing Voices, which shows how ABC is working with its Birds, Not Mosquitoes partners to prevent the extinction of the iconic native bird species in Hawai'i. This wonderful, hopeful video shares the gorgeous songs of these vanishing birds.
© Copyright by GrrlScientist | hosted by Forbes | LinkTr.ee
Socials: Bluesky | CounterSocial | LinkedIn | Mastodon Science | MeWe | Spoutible | SubStack | Threads | Tumblr | Twitter
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Bush, Obama and Bono bid farewell to USAID as researchers warn agency's closure means 14m extra deaths
Staff at the U.S. Agency for International Development (USAID) marked their final day on the job on Monday with tributes from two former presidents and a rock legend as new research revealed the stark reality of life without their help. George W Bush, Barack Obama and U2 frontman Bono expressed their thanks to departing employees from the international aid agency in heartfelt video messages as their offices were shuttered under President Donald Trump's 'America First' agenda. Secretary of State Marco Rubio announced in March that 83 percent of USAID's programs would be cut because they did not serve 'the core national interests of the United States,' with the remainder of the agency being folded into his department. But fresh doubt was cast on the wisdom behind that decision by findings published in The Lancet medical journal on the same day staff were saying goodbye, which indicated that 14 million more people will die over the next five years without the humanitarian support USAID once provided. An international team of researchers found the agency's global outreach efforts had prevented 92 million deaths between 2000 and 2021 across 133 countries, saving the lives of 25 million HIV/Aids sufferers, 11 million people with diarrheal diseases, 8 million with malaria and nearly 5 million with tuberculosis. Of the 14 million extra deaths, 4.5 million will be accounted for by children under five, they concluded. Davide Rasella of the Barcelona Institute for Global Health, one of the report's co-authors, called the findings 'striking' and said the likely impact on low and middle-income countries will be 'comparable in scale to a global pandemic or a major armed conflict.' He added that the cuts to USAID 'risk abruptly halting – and even reversing – two decades of progress in health among vulnerable populations.' The agency, founded in 1961, managed a budget of $35bn last year, according to the Congressional Research Service, and was involved in everything from running health clinics and building schools to more mundane but vital tasks like distributing nutrition pouches, mosquito nets and chlorine tablets. 'You've shown the great strength of America through your work, and that is our good heart,' Bush told the outgoing workers on Monday, according to The New York Times, also thanking them for enacting his signature Emergency Plan for Aids Relief. 'Is it in our interest that 25 million people who would have died now live? I think it is,' he said. 'On behalf of a grateful nation, thank you for your hard work, and God bless you.' Obama, in turn, attacked the decision to close USAID as 'a colossal mistake' and lamented: 'Ending your presence and your programs out in the world hurts the most vulnerable, and it hurts the United States. 'To many people around the world, USAID is the United States.' Bono, well known for his advocacy for developing nations, chose to deliver his message in rhyme and said: 'They called you crooks – when you were the best of us, there for the rest of us. And don't think any less of us, when politics makes a mess of us. 'It's not left-wing rhetoric to feed the hungry, heal the sick. If this isn't murder, I don't know what is.' The Lancet's forecast appeared to bear out his assessment and the research it published is by no means the only study to have anticipated such a bleak outcome from USAID's closure. A Boston University model, for instance, has put the human cost of its demise in even more shocking terms: 88 deaths per hour. Amira Albert Roess, a professor of global health and epidemiology at George Mason University, told NBC News it was the speed of the Trump administration's decision that is so dangerous. 'For better or for worse, some of the USAID-funded clinics in some areas, they were the main source of care,' she said. 'If you wanted to reduce USAID funding, it could have been done in a more gradual manner, instead of this sudden – and really, in a lot of places, overnight – shuttering of clinics.' Roess said she was particularly concerned by the abrupt closure of HIV clinics and warned: 'If you miss a dose or multiple doses, as was the case with lots of individuals, that's creating a situation where the individual can start to deteriorate fairly rapidly.' In May, Microsoft co-founder Bill Gates announced he would be bringing forward the charitable donation of $200bn from his personal fortune in order to help meet the shortfall and continue the fight against deadly diseases around the world. In doing so, Gates derided his fellow tech boss Elon Musk for his part in the cuts as the then-leader of Trump's Department of Government Efficiency (DOGE).


Washington Post
36 minutes ago
- Washington Post
Obesity drug prices are dropping, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven. 'The medications should be available, the question is at what price and can people sustain that,' said Matt Maciejewski, a Duke University professor who studies obesity treatment coverage.
Yahoo
an hour ago
- Yahoo
Obesity drug prices are dropping, but getting a steady supply remains a challenge
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without insurance — out of reach for many patients. And even for people with insurance, coverage remains uneven. 'The medications should be available, the question is at what price and can people sustain that,' said Matt Maciejewski, a Duke University professor who studies obesity treatment coverage. Doctors say the situation forces them to get creative in treating patients, but there's hope that prices may fall more in the future. The drugs are still in high demand Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity. Zepbound brought in $2.3 billion in U.S. sales during this year's first quarter, making it one of drugmaker Eli Lilly's best sellers. Novo Nordisk says Wegovy has about 200,000 weekly prescriptions in the U.S., where it brought in nearly $1.9 billion in first-quarter sales. Insurance coverage is increasing — for some The benefits consultant Mercer says more businesses with 500 or more employees are adding coverage of the injected drugs for their workers and family members. And Novo says 85% of its patients who have coverage in the U.S. pay $25 or less per month. Plus some patients with diabetes can get coverage of the GLP-1 drugs Ozempic and Mounjaro from Novo and Lilly that are approved to treat that condition. But most state and federally funded Medicaid programs don't cover the drugs for obesity and neither does Medicare, the federal program mainly for people age 65 and older. Even the plans that cover the drugs often pay only a portion of the bill, exposing patients to hundreds of dollars in monthly costs, said Dr. Beverly Tchang. Drugmakers offer help with these out-of-pocket costs, but that assistance can be limited. 'Coverage is not the same as access,' said Tchang, a New York-based doctor who serves as a paid advisor to both Novo and Lilly. But coverage remains inconsistent Bill-payers like employers are nervous about drugs that might be used by a lot of people indefinitely. Some big employers have dropped coverage of the drugs due to the expense. Pharmacy benefit managers, or PBMs, also are starting to pick one brand over the other as they negotiate deals with the drugmakers. One of the nation's largest PBMs, run by CVS Health, dropped Zepbound from its national formulary, or list of covered drugs, on July 1 in favor of Wegovy. That forced Tchang to figure out another treatment plan for several patients, many of whom took Zepbound because it made them less nauseous. Dr. Courtney Younglove's office sends prospective patients a video link showing them how to check their insurer's website for coverage of the drugs before they visit. 'Then some of them just cancel their appointment because they don't have coverage,' the Overland Park, Kansas, doctor said. Cheaper compounded drugs are still being sold Compounding pharmacies and other entities were allowed to make off-brand, cheaper copies of Wegovy and Zepbound when there was a shortage of the drugs. But the U.S. Food and Drug Administration determined earlier this year that the shortage had ended. That should have ended the compounded versions, but there is an exception: Some compounding is permitted when a drug is personalized for the patient. The health care company Hims & Hers Health offers compounded doses of semaglutide, the drug behind Wegovy, that adjust dose levels to help patients manage side effects. Hims says these plans start at $165 a month for 12 months, with customers paying in full upfront. It's a contentious issue. Eli Lilly has sued pharmacies and telehealth companies trying to stop them from selling compounded versions of its products. Novo recently ended a short-lived partnership with Hims to sell Wegovy because the telehealth company continued compounding. Novo says the compounded versions of its drug put patient safety at risk because ingredients are made by foreign suppliers not monitored by US regulators. Hims says it checks all ingredients to make sure they meet U.S. quality and safety standards. It also uses a third-party lab to verify that a drug's strength is accurately labeled. Prices have dropped Both drugmakers are selling most of their doses for around $500 a month to people without insurance, a few hundred dollars less than some initial prices. Even so, that expense would eat up about 14% of the average annual per person income in the U.S., which is around $43,000. There are some factors that may suppress prices over time. Both companies are developing pill versions of their treatments. Those could hit the market in the next year or so, which might drive down prices for the older, injectable doses. Younglove said some of her patients save as much as 15% by getting their doses shipped from a pharmacy in Canada. They used to get them from an Israeli pharmacy until the Canadians dropped their prices. She says competition like this, plus the introduction of pill versions, will pressure U.S. prices. 'I think price wars are going to drive it down,' she said. 'I think we are in the early stages. I have hope.' ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group. The AP is solely responsible for all content. Tom Murphy, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data